205 related articles for article (PubMed ID: 28164304)
1. Blood Group Antigen Matching Influence on Gestational Outcomes (AMIGO) study.
Delaney M; Wikman A; van de Watering L; Schonewille H; Verdoes JP; Emery SP; Murphy MF; Staves J; Flach S; Arnold DM; Kaufman RM; Ziman A; Harm SK; Fung M; Eppes CS; Dunbar NM; Buser A; Meyer E; Savoia H; Abeysinghe P; Heddle N; Tinmouth A; Traore AN; Yazer MH;
Transfusion; 2017 Mar; 57(3):525-532. PubMed ID: 28164304
[TBL] [Abstract][Full Text] [Related]
2. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
[TBL] [Abstract][Full Text] [Related]
3. Risk of maternal alloimmunization in Southern Pakistan - a study in a cohort of 1000 pregnant women.
Karim F; Moiz B; Kamran N
Transfus Apher Sci; 2015 Feb; 52(1):99-102. PubMed ID: 25532481
[TBL] [Abstract][Full Text] [Related]
4. Successful management of severe red blood cell alloimmunization in pregnancy with a combination of therapeutic plasma exchange, intravenous immune globulin, and intrauterine transfusion.
Nwogu LC; Moise KJ; Klein KL; Tint H; Castillo B; Bai Y
Transfusion; 2018 Mar; 58(3):677-684. PubMed ID: 29250791
[TBL] [Abstract][Full Text] [Related]
5. Red Blood Cell Alloimmunization in the Pregnant Patient.
Webb J; Delaney M
Transfus Med Rev; 2018 Oct; 32(4):213-219. PubMed ID: 30097223
[TBL] [Abstract][Full Text] [Related]
6. The risk to future pregnancies of transfusing Rh(D)-negative females of childbearing potential with Rh(D)-positive red blood cells during trauma resuscitation is dependent on their age at transfusion.
Seheult JN; Stram MN; Pearce T; Bub CB; Emery SP; Kutner J; Watanabe-Okochi N; Sperry JL; Takanashi M; Triulzi DJ; Yazer MH
Vox Sang; 2021 Aug; 116(7):831-840. PubMed ID: 33491789
[TBL] [Abstract][Full Text] [Related]
7. Impact of red blood cell alloimmunization on fetal and neonatal outcomes: A single center cohort study.
Lieberman L; Callum J; Cohen R; Cserti-Gazdewich C; Ladhani NNN; Buckstein J; Pendergrast J; Lin Y
Transfusion; 2020 Nov; 60(11):2537-2546. PubMed ID: 32893897
[TBL] [Abstract][Full Text] [Related]
8. Receipt of RhD-positive whole blood for life-threatening bleeding in female children: A survey in alloimmunized mothers regarding minimum acceptable survival benefit relative to risk of maternal alloimmunization to anti-D.
Sherwood MR; Clayton S; Leeper CM; Yazer M; Moise KJ; Granger ME; Spinella PC
Transfusion; 2024 May; 64 Suppl 2():S100-S110. PubMed ID: 38563495
[TBL] [Abstract][Full Text] [Related]
9. A descriptive single-centre experience of the management and outcome of maternal alloantibodies in pregnancy.
Chatziantoniou V; Heeney N; Maggs T; Rozette C; Fountain C; Watts T; Harrison C; Pasupathy D; Sankaran S; Kyle P; Robinson S
Transfus Med; 2017 Aug; 27(4):275-285. PubMed ID: 28608631
[TBL] [Abstract][Full Text] [Related]
10. Provision of KEL1-negative blood to obstetric patients: a 3-year single-institution retrospective review.
O'Brien KL; Kim YA; Haspel RL; Uhl L
Transfusion; 2015 Mar; 55(3):599-604; quiz 598. PubMed ID: 25118004
[TBL] [Abstract][Full Text] [Related]
11. Management and clinical consequences of red blood cell antibodies in pregnancy: A population-based cohort study.
Liu S; Ajne G; Wikman A; Lindqvist C; Reilly M; Tiblad E
Acta Obstet Gynecol Scand; 2021 Dec; 100(12):2216-2225. PubMed ID: 34476807
[TBL] [Abstract][Full Text] [Related]
12. Third trimester screening for alloimmunisation in Rhc-negative pregnant women: evaluation of the Dutch national screening programme.
Slootweg YM; Koelewijn JM; van Kamp IL; van der Bom JG; Oepkes D; de Haas M
BJOG; 2016 May; 123(6):955-63. PubMed ID: 26661943
[TBL] [Abstract][Full Text] [Related]
13. Neonatal and Obstetrical Outcomes of Pregnancies Complicated by Alloimmunization.
Bahr TM; Tweddell SM; Zalla JM; Dizon-Townson D; Ohls RK; Henry E; Ilstrup SJ; Kelley WE; Ling CY; Lindgren PC; O'Brien EA; Christensen RD
Pediatrics; 2024 Jun; 153(6):. PubMed ID: 38784990
[TBL] [Abstract][Full Text] [Related]
14. Perinatal risk factors associated with severity of haemolytic disease of the foetus and newborn due to Rhc maternal-foetal incompatibility: A retrospective cohort study.
Franchinard L; Maisonneuve E; Friszer S; Toly Ndour C; Huguet-Jacquot S; Maurice P; Mailloux A; Cortey A; Jouannic JM
Vox Sang; 2022 Apr; 117(4):570-579. PubMed ID: 34743337
[TBL] [Abstract][Full Text] [Related]
15. Red blood cell alloimmunization prevalence and hemolytic disease of the fetus and newborn in Israel: A retrospective study.
Rahimi-Levene N; Chezar J; Yahalom V;
Transfusion; 2020 Nov; 60(11):2684-2690. PubMed ID: 32770778
[TBL] [Abstract][Full Text] [Related]
16. Alloimmunization in sickle cell anemia in the era of extended red cell typing.
O'Suoji C; Liem RI; Mack AK; Kingsberry P; Ramsey G; Thompson AA
Pediatr Blood Cancer; 2013 Sep; 60(9):1487-91. PubMed ID: 23508932
[TBL] [Abstract][Full Text] [Related]
17. Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn.
Delaney M; Matthews DC
Hematology Am Soc Hematol Educ Program; 2015; 2015():146-51. PubMed ID: 26637714
[TBL] [Abstract][Full Text] [Related]
18. Jk3 alloantibodies during pregnancy-blood bank management and hemolytic disease of the fetus and newborn risk.
Lawicki S; Coberly EA; Lee LA; Johnson M; Eichbaum Q
Transfusion; 2018 May; 58(5):1157-1162. PubMed ID: 29479723
[TBL] [Abstract][Full Text] [Related]
19. Anti-Co(a) implicated in severe haemolytic disease of the foetus and newborn.
Michalewska B; Wielgos M; Zupanska B; Bartkowiak R
Transfus Med; 2008 Feb; 18(1):71-3. PubMed ID: 18179649
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with persistence of red blood cell antibodies in woman after pregnancies complicated by fetal alloimmune haemolytic disease treated with intrauterine transfusions.
Verduin EP; Brand A; van de Watering LM; Claas FH; Oepkes D; Lopriore E; Doxiadis II; Schonewille H
Br J Haematol; 2015 Feb; 168(3):443-51. PubMed ID: 25244566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
